Furthermore, growth arrest-specific protein 6 (GAS6) and serpin family G member 1 (SERPING1), two genes identified as key drivers of gene regulatory networks active in females with CAD, were found to be dominantly expressed in phenotypically altered plaque’s SMCs [3]. The gene discussed is GAS6; the disease is coronary artery disorder.